Recent advances of oxidative stress in thromboangiitis obliterans: biomolecular mechanisms, biomarkers, sources and clinical applications

Q Chen, J Chen, J Li, Y Cheng, R Zhang, Z Liu - Thrombosis Research, 2023 - Elsevier
Oxidative stress (OS) has been identified as a key factor in the development of
Thromboangiitis Obliterans (TAO). The detection of OS levels in clinical and scientific …

Risk factors, mechanisms and treatments of thromboangiitis obliterans: an overview of recent research

M Li, Y Wang, M Yang, F Hong… - Current Medicinal …, 2020 - ingentaconnect.com
Background: Thromboangiitis obliterans (TAO) is a nonatherosclerotic thromboticocclusive
vasculitis that affects the vessels of the small and medium-sized extremities. No explicit …

The imbalance among oxidative biomarkers and antioxidant defense systems in thromboangiitis obliterans (Winiwarter-Buerger Disease)

H Sharebiani, B Fazeli, R Maniscalco, D Ligi… - Journal of Clinical …, 2020 - mdpi.com
(1) Background: Thromboangiitis obliterans or Winiwarter-Buerger disease (WBD), is an
inflammatory, thrombotic occlusive, peripheral vascular disease, usually occurring in young …

[HTML][HTML] Buerger disease

E Qaja, E Muco, MF Hashmi - 2017 - europepmc.org
Buerger Disease - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe
PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog Tech …

Establishment of a multi-strategy platform for quality control and quality markers screen of Mailuoshutong pill

Y Chu, X Zhang, L Zuo, X Wang, Y Shi, L Liu… - … of Pharmaceutical and …, 2024 - Elsevier
Thromboangiitis obliterans (TAO) is a non-atherosclerotic segmental inflammatory occlusive
disease with a high recurrence rate, high disability rate, difficulty to cure, and poor …

[HTML][HTML] Association of Serum Asymmetric Dimethylarginine with the Severity of Coronary Artery Disease: A Pilot Study

L Goudhaman, AR Jagadeesan… - … of Biochemistry & …, 2021 - ncbi.nlm.nih.gov
Background: Asymmetric dimethylarginine (ADMA), an inhibitor of nitric oxide synthase
(NOS), has been implicated in endothelial dysfunction and atherogenesis. Though there is …

The IL-33/sST2 Axis in thromboangiitis obliterans

H Sharebiani, M Mohareri, A Mirhosseini… - Journal of Inflammation …, 2020 - Taylor & Francis
Background Until recently, it remains unknown whether thromboangiitis obliterans (TAO) is a
type of systemic vasculitis. A high level of IL-33 and its soluble decoy receptor sST2 in the …

A Meta-Analysis of Plasma Homocysteine in Buerger's Disease

M Merashli, T Bucci, D Pastori… - Thrombosis and …, 2022 - thieme-connect.com
Buerger's disease (BD) is a vascular inflammatory disease that commonly affects all three
layers of small and medium arteries of upper and lower extremities in a progressive and …